Myogenic responses of mouse isolated perfused renal afferent arterioles: Effects of salt intake and reduced renal mass

Hypertension

Volumn 55, Issue 4, 2010, Pages 983-989

  Lai, En Yin ^a   Onozato, Maristela L ^a   Solis, Glenn ^a   Aslam, Shakil ^a   Welch, William J ^a   Wilcox, Christopher S ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Chronic kidney disease; Hypertension; Kidney; Renal autoregulation; Salt sensitivity

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; AUTOREGULATION; BLOOD VESSEL TONE; BODY WEIGHT; CONTROLLED STUDY; GLOMERULOSCLEROSIS; KIDNEY MASS; KIDNEY PERFUSION; KIDNEY TUBULE PRESSURE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALT INTAKE; TELEMETRY; ALBUMINURIA; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; BLOOD PRESSURE; DRUG EFFECT; HOMEOSTASIS; KIDNEY; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VASOCONSTRICTION;

CREATININE;

ALBUMINURIA; ANALYSIS OF VARIANCE; ANIMALS; ARTERIOLES; BLOOD PRESSURE; CREATININE; HOMEOSTASIS; KIDNEY; MALE; MICE; MUSCLE, SMOOTH, VASCULAR; ORGAN SIZE; RANDOM ALLOCATION; SODIUM CHLORIDE, DIETARY; TELEMETRY; VASOCONSTRICTION;

EID: 77950513746     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.149120     Document Type: Article

References (43)

1. Hayashi K, Epstein M, Loutzenhiser R. Pressure-induced vasocon-striction of renal microvessels in normotensive and hypertensive rats: studies in the isolated perfused hydronephrotic kidney. Circ Res. 1989; 65:1475-1484.
2. Loutzenhiser R, Epstein M, Horton C. Inhibition by diltiazem of pressure-induced afferent vasoconstriction in the isolated perfused rat kidney. Am J Cardiol. 1987;59:72A-75A.
3. Cupples WA, Loutzenhiser RD. Dynamic autoregulation in the in vitro perfused hydronephrotic rat kidney. Am JPhysiol. 1998;275:F126-F130.
4. Takenaka T, Harrison-Bernard LM, Inscho EW, Carmines PK, Navar LG. Autoregulation of afferent arteriolar blood flow in juxtamedullary nephrons. Am J Physiol. 1994;267:F879-F887.
5. Bidani AK, Griffin KA, Williamson G, Wang X, Loutzenhiser R. Protective importance of the myogenic response in the renal circulation. Hypertens. 2009;54:393-398.
6. Dworkin LD, Benstein JA, Tolbert E, Feiner HD. Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease. J Am Soc Nephrol. 1996;7:437-442.
7. Li P, Mendonca M, Welch WJ, Wilcox CS. Salt-sensitive hypertension in a model of chronic renal failure is ameliorated by tempol. J Am Soc Nephrol. 2007;18:846A.
8. Weir MR, Dengel DR, Behrens MT, Goldberg AP. Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension. 1995;25:1339-1344.
9. Inscho EW, Pollock DM, Pollock JS, Cook AK. Attenuation of afferent arteriolar autoregulatory behavior by a high-salt diet involves activation of ETB receptors. Hypertens. 2009;54:e27.
10. Navar LG. Integrating multiple paracrine regulators of renal micro-vascular dynamics. Am J Physiol. 1998;274:F433-F444.
11. Carmines PK, Inscho EW, Gensure RC. Arterial pressure effects on preglomerular microvasculature of juxtamedullary nephrons. Am J Physiol. 1990;258:F94-F102.
12. Ito S, Juncos LA, Carretero OA. Pressure-induced constriction of the afferent arteriole of spontaneously hypertensive rats. Hypertension. 1992; 19:II164-II167.
13. Kawada N, Solis G, Ivey N, Connors S, Dennehy K, Modlinger P, Hamel R, Kawada JT, Imai E, Langenbach R, Welch W, Wilcox CS. Cycloox-ygenase-1-deficient mice have high sleep-to-wake blood pressure ratios and renal vasoconstriction. Hypertension. 2005;45:1131-1138.
14. Lai EY, Martinka P, Fahling M, Mrowka R, Steege A, Gericke A, Sendeski M, Persson PB, Persson AE, Patzak A. Adenosine restores angiotensin II-induced contractions by receptor-independent enhancement of calcium sensitivity in renal arterioles. Circ Res. 2006; 99:1117-1124.
15. Patzak A, Lai EY, Mrowka R, Steege A, Persson PB, Persson AEG. AT1 receptors mediate angiotensin II-induced release of nitric oxide in afferent arterioles. Kidney Int. 2004;66:1949-1958.
16. Kobayashi N, Hara K, Tojo A, Onozato ML, Honda T, Yoshida K, Mita S, Nakano S, Tsubokou Y, MatsuokaH. Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCe-MAPK-p90RSK, and Rho-kinase pathway. Hypertension. 2005;45:538-544.
17. Takahashi N, Boysen G, Li F, Li Y, Swenberg JA. Tandem mass spec-trometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate. Kidney Int. 2007;71:266-271.
18. Ma LJ, Fogo AB. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int. 2003;64:350-355.
19. Ylitalo P, Hepp R, Mohring J, Gross F. Effects of varying sodium intake on blood pressure and renin-angiotensin system in subtotally nephrec-tomized rats. J Lab ClinMed. 1976;88:807-816.
20. Smith S, Anderson S, Ballermann BJ, Brenner BM. Role of atrial natri-uretic peptide in adaptation of sodium excretion with reduced renal mass. J Clin Invest. 1986;77:1395-1398.
21. Koomans HA, Roos JC, Dorhout Mees EJ, Delawi IM. Sodium balance in renal failure. A comparison of patients with normal subjects under extremes of sodium intake. Hypertension. 1985;7:714-721.
22. Campese VM, Krol E. Neurogenic factors in renal hypertension. Curr Hypertens Rep. 2002;4:256-260.
23. Welch WJ, Wilcox CS. Macula densa arginine delivery and uptake in the rat regulates glomerular capillary pressure: effects of salt intake. J Clin Invest. 1997;100:2235-2242.
24. Mitch WE, Wilcox CS. Disorders of body fluids, sodium and potassium in chronic renal failure. Am J Med. 1982;72:536-550.
25. Correa-Rotter R, Hostetter TH, Manivel JC, Rosenberg ME. Renin expression in renal ablation. Hypertens. 1992;20:483-490.
26. Hofbauer KG, Zschiedrich H, Gross F. Regulation of renin release and intrarenal formation of angiotensin: studies in the isolated perfused rat kidney. Clin Exp Pharmacol Physiol. 1976;3:73-93.
27. Griffin KA, Picken M, Bidani AK. Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol. 1994;4:2023-2031.
28. Bidani AK, Mitchell KD, Schwartz MM, Navar LG, Lewis EJ. Absence of glomerular injury or nephron loss in a normotensive rat remnant kidney model. Kidney Int. 1990;38:28-38.
29. Just A, Arendshorst WJ. A novel mechanism of renal blood flow autoregulation and the autoregulatory role of A1 adenosine receptors in mice. Am J Physiol Renal Physiol. 2007;293:F1489-F1500.
30. Just A, Olson AJ, Whitten CL, Arendshorst WJ. Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catechol-amines by a mechanism independent of nitric oxide. Am J Physiol Heart Circ Physiol. 2007;292:H83-H92.
31. Just A, Arendshorst WJ. Dynamics and contribution of mechanisms mediating renal blood flow autoregulation. Am J Physiol Regul Integr Comp Physiol. 2003;285:R619-R631.
32. Inscho EW, Ohishi K, Navar LG. Effects of ATP on pre-and postglo-merular juxtamedullary microvasculature. Am J Physiol. 1992;263: F886-F893.
33. Fellner SK, Arendshorst WJ. Voltage-gated Ca2+ entry and ryanodine receptor Ca2 +-induced Ca2+ release in preglomerular arterioles. Am J Physiol Renal Physiol. 2007;292:F1568-F1572.
34. Moore LC, Casellas D. Tubuloglomerular feedback dependence of auto-regulationin rat juxtamedullary afferent arterioles. Kidney Int. 1990;37: 1402-1408. (Pubitemid 20198020)
35. Yuan BH, Robinette JB, Conger JD. Effect of angiotensin II and norepi-nephrine on isolated rat afferent and efferent arterioles. Am J Physiol. 1990;258:F741-F750.
36. Edwards RM. Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol. 1983;244:F526-F534.
37. Pelayo JC, Westcott JY. Impaired autoregulation of glomerular capillary hydrostatic pressure in the rat remnant nephron. J Clin Invest. 1991;88: 101-105.
38. Bidani AK, Schwartz MM, Lewis EJ. Renal autoregulation and vulnerability to hypertensive injury in remnant kidney. Am J Physiol. 1987;252: F1003-F1010.
39. Stohrer M, Boucher Y, Stangassinger M, Jain RK. Oncotic pressure in solid tumors is elevated. Cancer Res. 2000;60:4251-4255.
40. Loutzenhiser R, Bidani A, Chilton L. Renal myogenic response: kinetic attributes and physiological role. Circ Res. 2002;90:1316-1324.
41. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1985;76:612-619. (Pubitemid 15227525)
42. Salmond R, Seney FD Jr. Reset tubuloglomerular feedback permits and sustains glomerular hyperfunction after extensive renal ablation. Am J Physiol. 1991;260:F395-F401.
43. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1153-R1167.